TET2 is mutated/deleted with high frequencies in multiple forms of myeloid malignancies including MDS, CMML, MPN and AML. However, little is known regarding the biological function of TET2 and its role in the pathogenesis of myeloid malignancies. To study the function of TET2 in vivo, we generated a Tet2 knock out mouse model. Deletion of Tet2 in mice led to dramatic reduction in the 5-hydroxymethylcytosine levels and concomitant increase in the 5-methylcytosine levels in the 
; classified by the WHO as a myelodysplastic/myeloproliferative neoplasm), and acute myeloid leukemia (AML, up to 20%). [1] [2] [3] [4] [5] [6] [7] The majority of the TET2 alterations includes single-copy defects, double-copy defects, or nonsense/frameshift mutations, suggesting that the TET2 lesions likely result in loss of function. [1] [2] [3] [4] [5] [6] [7] Regions of uniparental disomy (usually harbor homozygous mutations) on chromosome 4 involving TET2 have been found in patients with these myeloid malignancies. [3] [4] [5] A number of investigators, therefore, have speculated that TET2 is a putative tumor suppressor gene of myelopoiesis that is strongly implicated in the pathogenesis of myeloid malignancies.
TET2 belongs to a three-member family that also includes TET1 and TET3; TET1 was originally identified as a partner for the MLL gene within t(10;11)(p12;q23) translocations in AML. 8, 9 All three paralogs share a highly homologous catalytic domain catalyzes the conversion of 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC), which could epigenetically regulate gene expression by altering methylation-driven gene silencing. [10] [11] [12] [13] [14] Therefore, TET2 might act as a tumor suppressor gene by regulating DNA methylation and epigenetic control of gene expression at critical loci important for myelopoiesis and leukemogenesis. The ability to inactivate ("knock out") candidate tumor suppressor genes in the mouse germ line provides a powerful tool for validating candidate tumor suppressor genes. 15 Almost all of the well studied tumor suppressor genes have been knocked out in the germ line of an inbred mouse strain, such as p53, NF1, AML1, APC, RB and VHL. [16] [17] [18] [19] [20] [21] The development of any type of tumor at an elevated frequency in such genetically altered mice adds persuasive evidence to support the candidacy of a gene as a tumor suppressor gene.
Delhommeau et al have shown that CD34 + hematopoietic stem cells (HSC) from two MPN/MDS patients with TET2 defects exhibited enhanced repopulating capacities compared to that of patients without TET2 defects in a NOD/SCID murine system. 4 Several reports have recently shown that small hairpin RNA-mediated depletion of Tet2 in murine hematopoietic precursors alters their cell differentiation towards monocyte/macrophage lineages in vitro. 12, 22 These results suggest that Tet2 is important for the regulation of normal hematopoiesis. However, the physiological function of Tet2 in vivo has not been defined to date, and the role of Tet2 in the development of myeloid malignancies remains to be elucidated.
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To challenge these critical scientific questions, we generated a Tet2-null murine model and analyzed the hematological phenotype associated with the loss of Tet2 function in mice. Our results demonstrate that deletion of Tet2 is sufficient to cause myeloid malignancies in mice and imply that TET2 functions as a tumor suppressor in myelopoiesis.
Materials and Methods
Construction of the Tet2-targeting vector and generation of Tet2-null mice. A nuclear ß-galactosidase (nlacZ) flanked by two loxP sites followed by a nuclear H2B-GFP (nGFP) and neomycin (Neo) was inserted 6 bp upstream of Tet2 start codon (cassette map: loxP-lacZ-polyA-loxP-H2B-GFPpolyA-FRT-Neo-FRT; endogenous ATG was disrupted) (Fig. 1A) . The 5' and 3' arms of the targeting vector were amplified on 129/sv mouse genomic DNA. The nlacZ/nGFP is expressed under the control of the endogenous Tet2 promoter. Since the endogenous ATG was disrupted, the Tet2:nlacZ/nGFP is also a heterozygous null for Tet2 (Tet2 +/-) after the recombination. The targeting vector was linearized and electroporated into 129/sv mouse ES cells, and subsequently screened by Southern blot (Fig. 1B) . Two positive clones were selected for the blastocyst (C57BL/6) injection.
Male chimeric mice were crossed to C57BL/6 females to screen for germ line transmission of Analysis of 5-hmC and 5-mC levels using dot blot. Levels of 5-hmC and 5-mC in BM cells were detected using dot blot as described previously. 12 Genomic DNA was isolated from BM cells of WT,
Tet2
+/-or Tet2 -/-mice. DNA samples were denatured and two-fold serial dilutions were spotted on nitrocellulose membranes in an assembled Bio-Dot apparatus according to manufacturer's instructions (Bio-Rad). The blotted membranes was washed with 2X SSC buffer, air-dried, vacuum-baked at 80°C for 2 hrs, blocked and incubated with anti-5-hmC or anti-5-mC antibody (1:1,000) overnight at 4 o C.
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Analyses of mice. PB was collected by retro-orbital bleeding of WT, Tet2 +/-and Tet2 -/-mice and was smeared for May-Grunwald-Giemsa staining, and/or subjected to an automated blood count (Hemavet System 950FS). Morphological analysis and cell differential of BM, spleen, and liver samples were performed on cytospins (5 × 10 5 total cells/sample) followed by May-Grunwald-Giemsa staining. For histopathology analyses, femurs were fixed in formaldehyde, decalcified, and paraffin embedded.
Spleens and livers were treated similarly except for the step of decalcification. Sections (4.5 µm) were stained with hematoxylin/eosin (H&E).
Flow cytometry analysis and hematopoietic progenitor cell (HPC) assay. Total white blood cells
were obtained after lysis of PB with a red cell lysis buffer. 25 Single-cell suspensions from BM, spleen, liver and PB were stained with panels of fluorochrome-conjugated antibodies. Flow cytometric analysis of HSCs and HPCs were performed as previously described. 26, 27 Dead cells were excluded by DAPI staining. The analyses were performed using a BD FACSCantoII or LSRII flow cytometer. All data were analyzed by BD FACSDiva 6.0 and/or FlowJo software. For colony-forming unit (CFU) assays, total BM or spleen cells isolated from each genotype of mice were plated in duplicate in methylcellulose medium (Methocult M3231, StemCell Technologies) supplemented with mIL-3, hIL-6, hEpo and mSCF, and scored in 8-10 days, whereas the CFU-erythroid (CFU-E) colonies were scored in 2 to 3 days. at a relatively high levels (Fig. 1D) . When GFP expression was analyzed in the total cell preparation of various organs/tissues, the majority of the cells in BM, spleen, thymus, liver, blood vessel, brain, sciatic nerve, lung, kidney, pancreas, intestine and skin expressed high levels of GFP; while a small proportion of the heart and bone cells exhibited high GFP expression (Supplemental Fig. 1 ). These results indicate that Tet2 is ubiquitously expressed in various organs/tissues and all of the HSCs express high levels of Tet2. Table 1 We next examined the levels of 5-hmC and 5-mC in the genomic DNA of BM cells from 6-7 week old WT, Tet2 +/-or Tet2 -/-mice using a dot blot assay as described previously. were sacrificed because of a moribund condition ( Fig. 3B -a) within one year of their life, whereas none of the WT mice (n=48) died at the endpoint of our evaluation (Fig. 3A) . Necropsy of the moribund/deceased Tet2 -/-or Tet2 +/-mice revealed pronounced splenomegaly, while Tet2 -/-mice also had profound hepatomegaly and 1/3 of these mice exhibited pale footpads suggesting anemia (Fig. 3B ).
Analyses of
Splenomegaly and hepatomegaly were more striking in the moribund/deceased Tet2 -/-mice, which were 8-15 times and 2-5 times larger than that of age-matched WT mice, respectively (Fig. 3C ). Fig. 3A ). In one of the moribund Tet2 -/-mice with Gr-1 + CD11b + cell infiltration (2A19), multiple white nodules were found in the liver, which also contained predominantly Gr-1 + CD11b + cells (Supplemental Fig. 3B ).
Interestingly, c-Kit expression was only observed on the infiltrated myeloid population in one animal (2A45, data not shown). In each of these moribund/deceased Tet2 -/-or Tet2 +/-mice, the proportion of B-and T-cells were comparable or decreased in the BM and spleen as compared to WT control mice (Fig. 3F) . Given the fact that thymus and lymph node histology were normal in these Tet2 -/-or Tet2 -/-mice, the reduced B-and T-cell population is likely relative to the predominance of erythroid or myeloid cell populations rather than a primary defect. Table 2 ). The latency of disease ranged from 47 to 117 days (Supplemental Table 2 Table 2 ). These data suggest that the Tet2-deletion induced myeloid malignancies with myeloid cell infiltration, but not erythroblast infiltration, are transplantable, indicating that these infiltrated myeloid cells are malignant in nature.
Based on the criteria of Bethesda proposals for classification of nonlymphroid hematopoietic neoplasms in mice 29 , these moribund/deceased Tet2 -/-mice developed a wide spectrum of myeloid malignancies, including MDS with erythroid predominance, CMML, MPD-like myeloid leukemia and myeloid leukemia with maturation (Table 2 ). These data demonstrate that deletion of Tet2 alone is sufficient to cause myeloid malignancies in mice. The development of myeloid malignancies in a significant percentage of Tet2 +/-mice indicates a haploinsufficiency effect of Tet2 on the pathogenesis of myeloid malignancies. Table 3 ). The colonies formed by Tet2 -/-LSK cells were predominantly high-proliferative potential-CFU-GM (Supplemental Table 3 ). LSK cells of various genotypes were also subjected to suspension cultures in 12-well plates with the same cytokine combinations. After 7 days of culture, the cells in each well were split into two tubes for either semisolid methycellulose cultures or cytospins. Tet2 -/-LSK cells generated more total cells and significantly greater numbers of total colonies-forming cells (CFCs) as compared to Tet2 +/-and WT LSK cells (Fig. 4 C, D) . In addition, cytospins of the cultured cells followed by May-Grünwald-Giemsa staining revealed that the progenies in the Tet2 -/-LSK cell culture contained a significantly higher percentage of myeloblasts and monocytes as compared to that in the Tet2 +/-and WT LSK cell cultures (Fig. 4 E) .
Deletion of
These data indicate that deletion of Tet2 in HSCs increases proliferative capacity and alters differentiation program which is skewed toward the monocytic lineage. The increased HSC pool and abnormal proliferation/differentiation of HSC/HPC in Tet2 -/-mice might facilitate the development of myeloid malignancies. In vitro hematopoietic colony-forming assays were performed with BM (1x10 4 ) and SP (1x10 5 ) cells from indicated genotypes of mice in the presence of mSCF, mIL-3, IL-6 and EPO. Colonies were enumerated on days 8 of cultures. Data are presented as mean ± SEM. * P < 0.05, ** P< 0.01. 
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